Phase 3 Tetanus Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
Prevent Whooping CoughPrevent DiphtheriaPrevent Tetanus
Changchun BCHT Biotechnology Co.1,650 enrolled1 locationNCT07112144
Recruiting
Phase 2Phase 3
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
DiphtheriaPoliomyelitisHepatitis B+3 more
LG Chem1,186 enrolled1 locationNCT06947499
Recruiting
Phase 3
A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection
Tetanus
Genrix (Shanghai) Biopharmaceutical Co., Ltd.582 enrolled20 locationsNCT06635798
Recruiting
Phase 3
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV
Diptheria ImmunizationTetanus ImmunizationPertussis Immunization+3 more
Serum Institute of India Pvt. Ltd.1,557 enrolled9 locationsNCT06413121